A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors

NCT06717022 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Mesothelin Positive Tumors

Interventions

BIOLOGICAL: CHT102 allogeneic CAR T cells

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]